Closing the Medication-Assisted Treatment Gap for Youth With Opioid Use Disorder.
作者信息
Saloner Brendan, Feder Kenneth A, Krawczyk Noa
机构信息
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland.
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland.
出版信息
JAMA Pediatr. 2017 Aug 1;171(8):729-731. doi: 10.1001/jamapediatrics.2017.1269.
Abstract
摘要
相似文献
1
Closing the Medication-Assisted Treatment Gap for Youth With Opioid Use Disorder.缩小患有阿片类药物使用障碍青少年的药物辅助治疗差距。
JAMA Pediatr. 2017 Aug 1;171(8):729-731. doi: 10.1001/jamapediatrics.2017.1269.
2
Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.美沙酮、丁丙诺啡和纳曲酮用于治疗孕妇阿片类物质使用障碍
Pharmacotherapy. 2017 Jul;37(7):824-839. doi: 10.1002/phar.1958. Epub 2017 Jul 2.
3
Medication-Assisted Treatment of Adolescents With Opioid Use Disorders.阿片类药物使用障碍青少年的药物辅助治疗。
Pediatrics. 2016 Sep;138(3). doi: 10.1542/peds.2016-1893. Epub 2016 Aug 22.
4
Naltrexone implant treatment for buprenorphine dependence--Mauritian case series.纳曲酮植入剂治疗丁丙诺啡依赖——毛里求斯病例系列
J Psychopharmacol. 2014 Aug;28(8):800-3. doi: 10.1177/0269881114528592. Epub 2014 Apr 2.
5
Medication-assisted treatment of opioid use disorder: review of the evidence and future directions.阿片类物质使用障碍的药物辅助治疗：证据综述与未来方向
Harv Rev Psychiatry. 2015 Mar-Apr;23(2):63-75. doi: 10.1097/HRP.0000000000000075.
6
Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone.接受美沙酮、丁丙诺啡或植入式纳曲酮治疗的阿片类药物依赖患者的致命和非致命阿片类药物过量情况。
Int J Drug Policy. 2017 Aug;46:54-60. doi: 10.1016/j.drugpo.2017.05.039. Epub 2017 Jun 10.
7
Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.一项扩大阿片类药物使用障碍治疗药物治疗处方者的劳动力发展干预措施的测试：一项群组随机试验的方案。
Implement Sci. 2017 Nov 15;12(1):135. doi: 10.1186/s13012-017-0665-x.
8
Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine.长效注射用纳曲酮诱导：纳曲酮与丁丙诺啡用于门诊阿片类药物脱毒的随机试验
Am J Psychiatry. 2017 May 1;174(5):459-467. doi: 10.1176/appi.ajp.2016.16050548. Epub 2017 Jan 10.
9
Sexual dysfunction among male patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence.男性阿片类药物依赖患者接受丁丙诺啡-纳曲酮维持治疗后的性功能障碍。
J Sex Med. 2012 Dec;9(12):3198-204. doi: 10.1111/j.1743-6109.2011.02219.x. Epub 2011 Mar 2.
10
A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls.阿回顾性队列研究产科结局阿片类药物依赖的女性治疗植入纳曲酮，口服美沙酮或舌下丁丙诺啡和非依赖对照组。
Drugs. 2017 Jul;77(11):1199-1210. doi: 10.1007/s40265-017-0762-9.
引用本文的文献
1
Exploring the Determinants of Treatment Completion Among Youth Who Received Medication-Assisted Treatment in the United States.探究美国接受药物辅助治疗的青少年完成治疗的决定因素。
Healthcare (Basel). 2025 Apr 2;13(7):798. doi: 10.3390/healthcare13070798.
2
Trends in Buprenorphine Dispensing Among Adolescents and Young Adults in the US.美国青少年和青年中丁丙诺啡配药情况的趋势
JAMA. 2025 Feb 4;333(5):425-427. doi: 10.1001/jama.2024.24121.
3
Client and program-level factors associated with planned use of medications for opioid use disorder in specialty substance use treatment programs: Evidence from linked administrative data and survey data.在专科物质使用治疗项目中，与阿片类物质使用障碍药物计划使用相关的服务对象和项目层面因素：来自关联行政数据和调查数据的证据
J Subst Use Addict Treat. 2025 Jan;168:209545. doi: 10.1016/j.josat.2024.209545. Epub 2024 Oct 21.
4
Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadership.州许可的专业物质使用治疗计划中使用丁丙诺啡的障碍和促进因素：对项目领导层的调查。
J Subst Use Addict Treat. 2024 Jul;162:209351. doi: 10.1016/j.josat.2024.209351. Epub 2024 Mar 17.
5
Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims.阿片类物质使用障碍患者中并存的精神障碍与丁丙诺啡使用差异：一项保险理赔分析
Drug Alcohol Depend Rep. 2023 Oct 20;9:100195. doi: 10.1016/j.dadr.2023.100195. eCollection 2023 Dec.
6
Health care use and cost of treatment for adolescents and young adults with opioid use disorder.青少年和青年成人群体中阿片类药物使用障碍的治疗保健使用和费用。
J Subst Use Addict Treat. 2023 Nov;154:209137. doi: 10.1016/j.josat.2023.209137. Epub 2023 Aug 7.
7
Buprenorphine Dispensing Among Youth Aged ≤19 Years in the United States: 2015-2020.美国≤19 岁青少年中丁丙诺啡的配给情况：2015-2020 年。
Pediatrics. 2023 Feb 1;151(2). doi: 10.1542/peds.2022-058755.
8
Patterns and contexts of polysubstance use among young and older adults who are involved in the criminal legal system and use opioids: A mixed methods study.在涉及刑事司法系统且使用阿片类药物的年轻和老年成年人中，多物质使用的模式和背景：一项混合方法研究。
J Subst Abuse Treat. 2022 Dec;143:108864. doi: 10.1016/j.jsat.2022.108864. Epub 2022 Aug 13.
9
"We need to build a better bridge": findings from a multi-site qualitative analysis of opportunities for improving opioid treatment services for youth.“我们需要搭建一座更好的桥梁”：关于改善青少年阿片类药物治疗服务机会的多地点定性分析结果
Harm Reduct J. 2022 Apr 17;19(1):37. doi: 10.1186/s12954-022-00623-7.
10
Access to Medications for Opioid Use Disorder and Associated Factors Among Adolescents and Young Adults: A Systematic Review.阿片类药物使用障碍药物的获取途径及其相关因素：系统评价。
JAMA Pediatr. 2022 Mar 1;176(3):304-311. doi: 10.1001/jamapediatrics.2021.4606.
本文引用的文献
1
Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014.2001-2014 年青少年和青年人群中阿片类物质使用障碍患者接受丁丙诺啡和纳曲酮治疗的趋势。
JAMA Pediatr. 2017 Aug 1;171(8):747-755. doi: 10.1001/jamapediatrics.2017.0745.
2
Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014.2003年至2014年商业健康计划对阿片类药物使用障碍特定治疗的覆盖情况。
J Psychoactive Drugs. 2017 Apr-Jun;49(2):102-110. doi: 10.1080/02791072.2017.1300360. Epub 2017 Mar 28.
3
Medication-Assisted Treatment for Adolescents in Specialty Treatment for Opioid Use Disorder.青少年阿片类物质使用障碍专科治疗中的药物辅助治疗
J Adolesc Health. 2017 Jun;60(6):747-750. doi: 10.1016/j.jadohealth.2016.12.023. Epub 2017 Mar 1.
4
Medication-Assisted Treatment of Adolescents With Opioid Use Disorders.阿片类药物使用障碍青少年的药物辅助治疗。
Pediatrics. 2016 Sep;138(3). doi: 10.1542/peds.2016-1893. Epub 2016 Aug 22.
5
Vermont responds to its opioid crisis.佛蒙特州应对其阿片类药物危机。
Prev Med. 2015 Nov;80:10-1. doi: 10.1016/j.ypmed.2015.04.002. Epub 2015 Apr 11.
6
Maintenance treatments for opiate -dependent adolescents.阿片类药物依赖青少年的维持治疗。
Cochrane Database Syst Rev. 2014 Jun 24;2014(6):CD007210. doi: 10.1002/14651858.CD007210.pub3.
7
How the affordable care act and mental health parity and addiction equity act greatly expand coverage of behavioral health care.《平价医疗法案》以及《精神健康平权与成瘾公平法案》如何大幅扩大行为健康护理的覆盖范围。
J Behav Health Serv Res. 2014 Oct;41(4):410-28. doi: 10.1007/s11414-014-9412-0.
8
Medication-assisted therapies--tackling the opioid-overdose epidemic.药物辅助治疗——应对阿片类药物过量流行问题
N Engl J Med. 2014 May 29;370(22):2063-6. doi: 10.1056/NEJMp1402780. Epub 2014 Apr 23.
9
Confronting the stigma of opioid use disorder--and its treatment.直面阿片类药物使用障碍的污名化现象及其治疗。
JAMA. 2014 Apr 9;311(14):1393-4. doi: 10.1001/jama.2014.2147.
10
Maintenance medication for opiate addiction: the foundation of recovery.阿片类药物成瘾维持治疗药物：康复的基础。
J Addict Dis. 2012;31(3):207-25. doi: 10.1080/10550887.2012.694598.
Zotero 插件